Kombucha

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: digestion immunity detox

Research Overview

Overall, kombucha research is dominated by compositional, microbiological, and process-focused studies rather than human clinical research. The most studied areas include (i) characterization of the fermentation ecology (acetic acid bacteria and yeasts in the SCOBY; increasingly using modern genetic identification methods), (ii) fermentation biochemistry and metabolite profiling (e.g., dynamics of sucrose hydrolysis, ethanol formation and oxidation to acetic acid, organic acid production, pH reduction), and (iii) how inputs and conditions (tea type, sugar source and concentration, fermentation time/temperature, brewing parameters, and SCOBY composition) influence bioactive compound content (phenolics, vitamins), sensory properties, and product safety parameters (notably pH and alcohol content). A smaller but active subset of studies explores novel substrates/tea cultivars (e.g., anthocyanin-rich Zijuan tea) and compares physicochemical and antioxidant properties across formulations.

The strongest evidence supported by the abstracts is that kombucha is a microbially fermented sugared tea that reliably generates organic acids and other fermentation-derived metabolites, producing a low-alcohol, acidic beverage with measurable antioxidant and antimicrobial activity in vitro and in product-chemistry assays. Reviews consistently report that these activities and bioactive compound levels vary substantially with raw materials and fermentation parameters, and that kombucha’s putative health effects (e.g., antidiabetic, anticarcinogenic, cardiometabolic, immune, and liver-related claims) are largely inferred from mechanistic plausibility, in vitro/animal findings, or analogy to tea polyphenols and other fermented foods rather than demonstrated in humans. Notably, the fermented-foods gastrointestinal health literature cited indicates an absence of randomized controlled trials (RCTs) testing kombucha for gastrointestinal outcomes, in contrast to some other fermented foods (e.g., kefir).

Key research gaps include well-controlled human clinical studies to evaluate claimed benefits, including gastrointestinal and cardiometabolic endpoints, and to link outcomes to defined product compositions. Additional needs are standardization and transparency in microbial community definition (SCOBY variability), clearer mapping of microorganism-specific roles in biotransformation of tea constituents and phenolics, and improved understanding of safety and adverse effects—particularly given variability in acidity and alcohol content and the continued uncertainty around toxic effects. Future work would benefit from harmonized production/analytical protocols, dose–response assessment, and regulatory-relevant characterization to ensure reproducible quality, safety, and interpretability across studies.

1. What conditions has Kombucha been studied for?

  • In humans: The abstracts indicate kombucha has been studied in very limited human subjects research. One systematic review (searching PubMed/Scopus/Ovid through July 2018) found only one human study reporting empirical results, and found no registered clinical trials in major trial registries at that time.

  • Gastrointestinal (GI) health: A broader fermented-foods review notes no randomized controlled trials (RCTs) of kombucha for GI health outcomes, despite many in vitro studies.

  • Conditions commonly claimed/studied in non-human literature (preclinical/in vitro/animal): Multiple kombucha reviews in the abstracts describe research or claimed effects related to:

    • Cancer/anticarcinogenic effects (often framed as “cancer prevention” or “antitumoral” activity).

    • Cardiovascular-related outcomes (e.g., “cardiovascular diseases,” “antihypertensive,” “hypocholesterolemic”).

    • Metabolic disease (notably antidiabetic effects).

    • Liver-related outcomes (e.g., “hepatoprotective,” “promote liver functions,” “detoxifying”).

    • Immune effects (e.g., “stimulate the immune system,” “anti-inflammatory”).

    • Antimicrobial activity.

2. Does it work in treating those conditions? Summarize the evidence.

  • Overall conclusion from the abstracts: There is insufficient human clinical evidence to conclude that kombucha treats or prevents the conditions it is commonly promoted for.

  • GI outcomes: The fermented-foods review explicitly states there are no RCTs investigating kombucha’s impact on gastrointestinal health, even though other fermented foods (e.g., kefir, sauerkraut, natto, sourdough) have at least one RCT in GI contexts.

  • Human subjects evidence base: The systematic review of kombucha and human subjects research found only one human study with empirical results and no ongoing registered trials at the time of the search. This implies the evidence is too sparse to support treatment claims.

  • Preclinical evidence: Multiple reviews summarize in vitro and other non-human findings suggesting antioxidant, antimicrobial, antidiabetic, anti-inflammatory, antihypertensive, hepatoprotective, hypocholesterolemic, and antitumoral activities. However, these abstracts repeatedly emphasize that clinical studies in humans are needed before drawing firm conclusions.

  • Comparative claim vs. black tea: One review notes reports suggesting kombucha’s protective effects may be “as good as those of black tea,” but also states that more studies on composition and effects are needed before final conclusions.

3. What health benefits does it have?

  • Most consistently described potential benefits (largely preclinical):

    • Antioxidant activity: Several reviews describe “strong antioxidant” properties and high content of bioactive compounds (e.g., polyphenols), with activity influenced by tea type, brewing, SCOBY composition, and fermentation parameters.

    • Antimicrobial activity: Reviews repeatedly attribute antimicrobial properties to kombucha, linked to fermentation metabolites such as organic acids.

    • Metabolic/cardiometabolic signals: Reviews list antidiabetic, antihypertensive, and hypocholesterolemic activities as reported in the literature, but emphasize limited human evidence.

    • Liver-related effects: Reviews describe “hepatoprotective” effects and claims of promoting liver function, again with limited human confirmation.

    • Anti-inflammatory and immune-related effects: Reviews mention anti-inflammatory activity and immune stimulation as proposed benefits.

    • Potential probiotic-related effects: Kombucha contains a symbiotic culture of bacteria and yeasts (SCOBY). Reviews discuss microbial diversity (acetic acid bacteria, lactic acid bacteria, yeasts) and propose microbiota modulation as a mechanism, but the abstracts do not provide RCT evidence for kombucha specifically.

  • Product-dependent nature of benefits: Multiple abstracts stress that kombucha’s composition varies widely with substrate (tea type, added substrates), sugar amount, fermentation time/temperature, and SCOBY composition, which substantially affects organic acids, phenolics, vitamins, and alcohol content—therefore any “benefit” is unlikely to be uniform across products.

  • Example of enhanced antioxidant profile (food science evidence): A study using anthocyanin-rich Zijuan tea reported the resulting kombucha had higher overall acceptability, antioxidant activity, and volatile compounds than black- or green-tea kombucha, illustrating that tea cultivar can meaningfully change the beverage’s chemical and antioxidant profile (this is not a clinical outcome).

4. Does it have any downsides or side effects?

  • Safety uncertainties: One review states that toxic effects associated with kombucha consumption are still unclear, highlighting uncertainty rather than confirming safety.

  • Groups advised to avoid kombucha (per one abstract): Due to the possibility of adverse reactions, consumption was described as contraindicated in:

    • Infants

    • Pregnant women

    • Children under 4 years old

    • Patients with kidney failure

    • Patients with HIV

  • Alcohol and acidity considerations: Kombucha fermentation produces ethanol (from yeast metabolism) which is then oxidized by acetic acid bacteria to acetic acid, lowering pH. Reviews note kombucha is a low-alcohol beverage and that regulations focus on pH and alcohol content to ensure quality and safety. This implies potential downsides include variable alcohol levels and high acidity depending on fermentation conditions.

  • Variability and lack of standardization: Multiple reviews emphasize “many unknowns” and often undefined microbial compositions and production methods, which can lead to inconsistent metabolite profiles (organic acids, phenolics, alcohol). This variability is a practical safety and tolerability concern because consumers may not be getting a consistent product.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not discuss pharmacogenomic interactions or genotype-specific benefits/harms of kombucha (e.g., variants affecting alcohol metabolism, caffeine metabolism, histamine/amine metabolism, or polyphenol metabolism). Therefore, based on these abstracts alone, there is no evidence to conclude that kombucha is beneficial or harmful for specific genetic variations.

Given that kombucha can contain variable alcohol and diverse bioactive compounds depending on fermentation conditions, pharmacogenomic hypotheses are plausible, but they are not evaluated in the cited abstracts and would require targeted human studies.

References

  1. Fermented Foods: Definitions and Characteristics, Impact on the Gut Microbiota and Effects on Gastrointestinal Health and Disease.
    Eirini Dimidi, Selina Rose Cox, Megan Rossi, Kevin Whelan (2019) - Nutrients
  2. A Review on Kombucha Tea-Microbiology, Composition, Fermentation, Beneficial Effects, Toxicity, and Tea Fungus.
    Rasu Jayabalan, Radomir V Malbaša, Eva S Lončar, Jasmina S Vitas, Muthuswamy Sathishkumar (2014) - Comprehensive reviews in food science and food safety
  3. Kombucha: A review of substrates, regulations, composition, and biological properties.
    Jeniffer Ferreira de Miranda, Larissa Fernandes Ruiz, Cíntia Borges Silva, Thais Matsue Uekane, Kelly Alencar Silva, Alice Gonçalves Martins Gonzalez, Fabrício Freitas Fernandes, Adriene Ribeiro Lima (2022) - Journal of food science
  4. Kombucha Tea-A Double Power of Bioactive Compounds from Tea and Symbiotic Culture of Bacteria and Yeasts (SCOBY).
    Hubert Antolak, Dominik Piechota, Aleksandra Kucharska (2021) - Antioxidants (Basel, Switzerland)
  5. Health-promoting properties ofSaccharomyces cerevisiae var. boulardiias a probiotic; characteristics, isolation, and applications in dairy products
    Fereshteh Ansari, Shohre Alian Samakkhah, Ali Bahadori, Seyedeh Maedeh Jafari, Mojtaba Ziaee (2023)
  6. Kombucha: Production and Microbiological Research.
    Boying Wang, Kay Rutherfurd-Markwick, Xue-Xian Zhang, Anthony N Mutukumira (2022) - Foods (Basel, Switzerland)
  7. Zijuan tea- based kombucha: Physicochemical, sensorial, and antioxidant profile.
    Chun Zou, Ru-Yi Li, Jian-Xin Chen, Fang Wang, Ying Gao, Yan-Qing Fu, Yong-Quan Xu, Jun-Feng Yin (2021) - Food chemistry
  8. Effect of kombucha intake on the gut microbiota and obesity-related comorbidities: A systematic review.
    Mirian Aparecida de Campos Costa, Darlene Larissa de Souza Vilela, Gabriela Macedo Fraiz, Isabelle Lima Lopes, Ana Iris Mendes Coelho, Luiza Carla Vidigal Castro, José Guilherme Prado Martin (2023) - Critical reviews in food science and nutrition
  9. Fermented Beverage Benefits: A Comprehensive Review and Comparison of Kombucha and Kefir Microbiome.
    Ann Qi Chong, Siew Wen Lau, Nyuk Ling Chin, Rosnita A Talib, Roseliza Kadir Basha (2023) - Microorganisms
  10. Kombucha: a systematic review of the empirical evidence of human health benefit.
    Julie M Kapp, Walton Sumner (2019) - Annals of epidemiology
  11. Recent advances in Kombucha tea: Microbial consortium, chemical parameters, health implications and biocellulose production.
    Iñaki Diez-Ozaeta, Oihana Juaristi Astiazaran (2022) - International journal of food microbiology
  12. Multidisciplinary advances in kombucha fermentation, health efficacy, and market evolution.
    Karan Prajapati, Jignesh Prajapati, Dhaval Patel, Rohit Patel, Anish Varshnei, Meenu Saraf, Dweipayan Goswami (2024) - Archives of microbiology
  13. Consumer's acceptability and health consciousness of probiotic and prebiotic of non-dairy products.
    Fernanda Cosme, António Inês, Alice Vilela (2022) - Food research international (Ottawa, Ont.)
  14. Comparison of Anti-Inflammatory and Antibacterial Properties of
    Aleksandra Ziemlewska, Martyna Zagórska-Dziok, Agnieszka Mokrzyńska, Zofia Nizioł-Łukaszewska, Dariusz Szczepanek, Ireneusz Sowa, Magdalena Wójciak (2024) - International journal of molecular sciences
  15. Changes in the chemical compositions and biological properties of kombucha beverages made from black teas and pineapple peels and cores.
    Ly Tu Phung, Haruthairat Kitwetcharoen, Nuttaporn Chamnipa, Nongluck Boonchot, Sudarat Thanonkeo, Patcharaporn Tippayawat, Preekamol Klanrit, Mamoru Yamada, Pornthap Thanonkeo (2023) - Scientific reports
  16. Fermentation Technology and Functional Foods.
    Domenico Giuffrè, Angelo Maria Giuffrè (2024) - Frontiers in bioscience (Elite edition)
  17. Kombucha from alternative raw materials - The review.
    Katarzyna Ewa Emiljanowicz, Edyta Malinowska-Pańczyk (2020) - Critical reviews in food science and nutrition
  18. Kombucha Beverages Produced from Fruits, Vegetables, and Plants: A Review on Their Pharmacological Activities and Health Benefits.
    Natthinee Anantachoke, Ratchanee Duangrat, Tanyarat Sutthiphatkul, Duangjai Ochaikul, Supachoke Mangmool (2023) - Foods (Basel, Switzerland)
  19. Bioactive compounds in kombucha: A review of substrate effect and fermentation conditions.
    Bruna Milena Bortolomedi, Camila Souza Paglarini, Fábio Cristiano Angonesi Brod (2022) - Food chemistry
  20. Traditional Fermented Foods and Beverages from around the World and Their Health Benefits.
    Leonel Cuamatzin-García, Paola Rodríguez-Rugarcía, Elie Girgis El-Kassis, Georgina Galicia, María de Lourdes Meza-Jiménez, Ma Del Rocío Baños-Lara, Diego Salatiel Zaragoza-Maldonado, Beatriz Pérez-Armendáriz (2022) - Microorganisms


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!